For comments, suggestions
Created with Raphaël 2.1.0 03.05.2022 Filing date 24.10.2023 Validation fee payment 31.03.2024 (A1) Patent application published 28.11.2025 AGEPI application filing date 28.02.2026 (T2) Translation of the validated European patent 31.05.2026 03.05.2027 Valid until 04.05.2028 Renewal fee to be paid until 03.05.2042 Patent will expire on

Patent in force


(210)Number of the EPO application22725046
(220)Filing date of the EPO application2022.05.03
(80)EPO patent specification publication (B)EPB nr. 45/2025, 2025.11.05
(110)EPO patent number4333840
(11)Number of the documentMD 4333840 T2
(21)Number of the applicatione 2024 0289
(71)Name(s) of applicant(s), code of the countryINCYTE CORPORATION, US;
(72)Name(s) of inventor(s), code of the countrySMITH Paul, US;
BROWN Kurt Andrew, US;
(73)Name(s) of owner(s), code of the countryINCYTE CORPORATION, US;
(54)Title of the inventionJak1 pathway inhibitors for the treatment of prurigo nodularis
(13)Kind-of-document code T2
(51)International Patent Classification A61K 31/4155 (2006.01.01); A61K 31/519 (2006.01.01); A61K 31/5377 (2006.01.01); A61K 39/395 (2006.01.01); A61K 45/06 (2006.01.01); A61P 17/00 (2006.01.01); A61P 17/04 (2006.01.01); C07K 16/24 (2006.01.01)
(52)Cooperative Patent Classification A61K 45/06 (EP); A61K 31/4155 (EP); A61K 31/519 (EP); A61K 31/5377 (EP); A61K 39/3955 (EP); A61P 17/00 (EP); A61P 17/04 (EP); C07K 16/244 (EP); C07K 16/247 (EP)
(19)CountryUS
(41)Date of publication of the application2024.03.31
(49)Date of publication of the translation of the validated European patent specification2026.02.28
(30)Priority202163183249 P, 2021.05.03, US
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
(86)International applicationPCT/US2022/027389, 2022.05.03
(87)International publicationWO 2022/235613, 2022.11.10
Up
/Inventions/details/4333840